Assets for Independence Evaluation
Public ClinicalTrials.gov record NCT02383303. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Assets for Independence (AFI) Program Evaluation: a Randomized Control Trial of Matched Savings Accounts (Individual Development Accounts or IDAs) for Low-income Households.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The U.S. Department of Health and Human Services, Administration for Children and Families (ACF) is conducting an experimental evaluation of the Assets for Independence (AFI) Program. This evaluation-the first experimental evaluation of Individual Development Account (IDA) projects operating under the Assets for Independence Act-will contribute importantly to understanding the effects of IDA projects and IDA project features on participants. IDA programs provide matching funds to participants when the savings are withdrawn to spend on qualified asset purchases, most commonly homeownership, business-related expenses, or education. This study will build on the prior quasi-experimental AFI evaluation, as well as studies of other non-AFI funded Individual Development Account (IDA) projects. While some evaluations suggest that IDAs help low-income families save, rigorous experimental research is limited. No experimental evaluation of AFI-funded programs has been conducted to date. Of the quasi- or non-experimental studies, few have focused on AFI-funded IDAs. The evaluation is being conducted in two sites, with the random assignment of 299 AFI-eligible cases in one site and 509 cases in the other, for a total of 808 cases. Each site randomly assigned sample members to one of two groups: a control group and a treatment group receiving conventional AFI services. The primary research questions the study seeks to answer are: 1. What are the impacts of AFI program participation on the outcomes it is designed to address (e.g., savings and asset purchases)? 2. What are the impacts of AFI program participation on other outcome domains that the program might influence (e.g., material hardship, alternative financial product use, economic well-being)? 3. How do the impacts of AFI program participation vary over time and by participant characteristics? The study uses a two-armed (treatment vs. control) experimental design. This design allows the first two questions above to be addressed using a rigorous randomized approach. In addition to the impact study, the evaluation includes an implementation study to describe and document how the AFI program is designed, implemented and operated in the participating grantee sites during the time of the study. This information will be used to provide context for interpreting the findings of the impact study.
Study identification
- NCT ID
- NCT02383303
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 808 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2012
- Primary completion
- Aug 31, 2019
- Completion
- Aug 31, 2019
- Last update posted
- May 10, 2017
2013 – 2019
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| RISE Financial Pathways | Los Angeles | California | 90037 | — |
| Prosperity Works | Albuquerque | New Mexico | 87102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02383303, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 10, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02383303 live on ClinicalTrials.gov.